Last 7 days
-3.1%
Last 30 days
-12.0%
Last 90 days
2.2%
Trailing 12 Months
-4.7%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-09-19 | LaBarre Michael J. | acquired | 199,800 | 19.98 | 10,000 | svp, chief technical officer |
2023-09-19 | LaBarre Michael J. | sold | -390,980 | 39.098 | -10,000 | svp, chief technical officer |
2023-08-31 | Torley Helen | sold | -428,170 | 42.817 | -10,000 | president and ceo |
2023-08-31 | Torley Helen | acquired | 138,700 | 13.87 | 10,000 | president and ceo |
2023-08-30 | Torley Helen | acquired | 138,700 | 13.87 | 10,000 | president and ceo |
2023-08-30 | Torley Helen | sold | -428,540 | 42.854 | -10,000 | president and ceo |
2023-08-29 | Torley Helen | sold | -424,020 | 42.402 | -10,000 | president and ceo |
2023-08-29 | Torley Helen | acquired | 138,700 | 13.87 | 10,000 | president and ceo |
2023-08-22 | LaBarre Michael J. | acquired | 196,778 | 19.6778 | 10,000 | svp, chief technical officer |
2023-08-22 | LaBarre Michael J. | sold | -424,070 | 42.407 | -10,000 | svp, chief technical officer |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-20 | BARCLAYS PLC | added | 44.29 | 2,695,000 | 10,129,000 | 0.01% |
2023-09-18 | WASHINGTON CAPITAL MANAGEMENT, INC | unchanged | - | -32,860 | 559,085 | 0.48% |
2023-09-12 | Farther Finance Advisors, LLC | added | 500 | 891 | 1,082 | -% |
2023-08-29 | EFG Asset Management (Americas) Corp. | added | 20.00 | 34,005 | 288,885 | 0.07% |
2023-08-24 | Alberta Investment Management Corp | new | - | 558,003 | 558,003 | -% |
2023-08-23 | Rehmann Capital Advisory Group | unchanged | - | -745 | 36,545 | -% |
2023-08-22 | VIRGINIA RETIREMENT SYSTEMS ET AL | reduced | -95.00 | -7,641,160 | 378,735 | -% |
2023-08-21 | OSAIC HOLDINGS, INC. | added | 32.2 | 121,837 | 594,734 | -% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -6.95 | -813,053 | 5,900,370 | 0.01% |
2023-08-21 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | added | 10.27 | 35,000 | 879,000 | 0.01% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Jun 09, 2023 | vanguard group inc | 10.27% | 13,528,630 | SC 13G/A | |
Feb 10, 2023 | invesco ltd. | 5.2% | 7,036,951 | SC 13G | |
Feb 10, 2023 | blackrock inc. | 14.2% | 19,196,061 | SC 13G/A | |
Feb 10, 2023 | artisan partners limited partnership | 5.3% | 7,140,953 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 9.84% | 13,303,847 | SC 13G/A | |
Jan 26, 2023 | blackrock inc. | 13.6% | 18,214,071 | SC 13G/A | |
Jan 20, 2023 | blackrock inc. | 13.6% | 18,214,071 | SC 13G | |
Feb 04, 2022 | artisan partners limited partnership | 6.8% | 9,505,768 | SC 13G/A | |
Jan 28, 2022 | blackrock inc. | 13.8% | 19,439,863 | SC 13G/A | |
Feb 12, 2021 | bb biotech ag | 2.9% | 3,970,000 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 19, 2023 | 144 | Notice of Insider Sale Intent | |
Sep 19, 2023 | 4 | Insider Trading | |
Sep 07, 2023 | 8-K | Current Report | |
Aug 31, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 31, 2023 | 4 | Insider Trading | |
Aug 30, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 29, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 23, 2023 | 4 | Insider Trading | |
Aug 22, 2023 | 144 | Notice of Insider Sale Intent | |
Aug 17, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
AMGN | 142.4B | 26.6B | 3.74% | 20.01% | 17.85 | 5.36 | 0.75% | 21.34% |
GILD | 92.4B | 27.4B | -3.33% | 22.27% | 16.85 | 3.37 | -0.48% | 32.56% |
MRNA | 39.4B | 10.7B | -8.22% | -12.63% | 32.61 | 3.69 | -53.67% | -91.41% |
BIIB | 36.6B | 10.0B | -5.36% | -5.30% | 13.73 | 3.67 | -6.23% | 29.40% |
MID-CAP | ||||||||
NBIX | 10.9B | 1.7B | 1.05% | 5.25% | 61.85 | 6.52 | 29.01% | 1345.90% |
BBIO | 4.1B | - | -16.91% | 155.63% | -7.02 | 48.33 | 54.84% | -12.96% |
DNLI | 2.7B | - | -15.10% | -35.52% | -21.18 | 37.44 | 122.90% | 54.78% |
BEAM | 1.7B | 80.2M | -8.35% | -54.87% | -5.12 | 20.91 | 42.17% | -39.82% |
SMALL-CAP | ||||||||
RCUS | 1.3B | 121.2M | -18.44% | -33.91% | -4.48 | 10.62 | -70.36% | -531.73% |
REPL | 931.2M | 15.3M | -19.93% | -8.57% | -5.13 | 60.82 | 1090.59% | -36.57% |
NVAX | 668.6M | 1.6B | -13.64% | -61.04% | -1.14 | 0.42 | 23.74% | 60.24% |
FATE | 189.2M | - | -31.67% | -91.43% | -0.89 | 1.38 | 116.83% | 16.61% |
VXRT | 113.0M | 2.1M | -10.53% | -65.89% | -1.12 | 55 | 487.70% | -8.66% |
SGMO | 104.6M | - | -38.94% | -87.76% | -0.53 | 0.43 | 113.96% | -15.19% |
IBIO | 6.3M | - | 5.48% | -92.77% | -0.08 | 3.21 | - | -129.46% |
13.2%
17.4%
15.1%
13.5%
85.4%
28.5%
11.2%
Y-axis is the maximum loss one would have experienced if Halozyme Therapeutics was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | 9.7% | 774 | 705 | 660 | 581 | 487 | 472 | 443 | 463 | 412 | 331 | 268 | 200 | 180 | 164 | 196 | 203 | 182 | 178 | 152 | 281 | 319 |
Costs and Expenses | 1.8% | 468 | 459 | 393 | 331 | 246 | 171 | 167 | 166 | 151 | 133 | 123 | 165 | 211 | 238 | 264 | 238 | 218 | 221 | 221 | 225 | 229 |
S&GA Expenses | -11.1% | 149 | 167 | 144 | 120 | 98.00 | 53.00 | 50.00 | 47.00 | 46.00 | 44.00 | 46.00 | 59.00 | 66.00 | 72.00 | 77.00 | 71.00 | 68.00 | 65.00 | 61.00 | 58.00 | 56.00 |
R&D Expenses | 5.8% | 77.00 | 73.00 | 67.00 | 54.00 | 46.00 | 39.00 | 36.00 | 33.00 | 32.00 | 33.00 | 34.00 | 72.00 | 95.00 | 120 | 141 | 132 | 137 | 144 | 150 | 155 | 153 |
EBITDA | -100.0% | - | 255 | 272 | 252 | 245 | 305 | 259 | 281 | 246 | 184 | 153 | 44.00 | -19.82 | -62.49 | -56.56 | - | - | - | - | - | - |
EBITDA Margin | -100.0% | - | 0.36* | 0.41* | 0.43* | 0.50* | 0.65* | 0.58* | 0.61* | 0.60* | 0.55* | 0.57* | 0.22* | -0.11* | -0.38* | -0.29* | - | - | - | - | - | - |
Interest Expenses | 7.0% | 21.00 | 20.00 | 17.00 | 14.00 | 9.00 | 7.00 | 8.00 | 11.00 | 14.00 | 17.00 | 20.00 | 19.00 | 16.00 | 14.00 | 12.00 | 12.00 | 14.00 | 16.00 | 18.00 | 20.00 | 21.00 |
Earnings Before Taxes | 27.8% | 290 | 227 | 249 | 233 | 233 | 295 | 249 | 267 | 229 | 163 | 129 | 22.00 | -39.68 | -80.16 | -72.25 | -39.60 | -42.45 | -50.70 | -79.79 | 44.00 | 75.00 |
EBT Margin | -100.0% | - | 0.32* | 0.38* | 0.40* | 0.48* | 0.63* | 0.56* | 0.58* | 0.56* | 0.49* | 0.48* | 0.11* | -0.22* | -0.49* | -0.37* | - | - | - | - | - | - |
Net Income | 28.7% | 234 | 182 | 202 | 211 | 366 | 435 | 403 | 409 | 229 | 163 | 129 | 22.00 | -39.70 | -80.14 | -72.24 | -39.97 | -42.80 | -51.07 | -80.33 | 46.00 | 76.00 |
Net Income Margin | -100.0% | - | 0.26* | 0.31* | 0.36* | 0.75* | 0.92* | 0.91* | 0.88* | 0.55* | 0.49* | 0.48* | 0.11* | -0.22* | -0.49* | -0.37* | - | - | - | - | - | - |
Free Cashflow | -100.0% | - | 264 | 235 | 238 | 290 | 287 | 298 | 265 | 150 | 116 | 53.00 | -23.54 | -60.14 | -89.07 | -89.46 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | 6.5% | 1,810 | 1,699 | 1,842 | 1,865 | 1,781 | 1,162 | 1,104 | 1,185 | 1,026 | 967 | 580 | 524 | 527 | 492 | 566 | 370 | 418 | 429 | 440 | 445 | 475 |
Current Assets | 24.5% | 766 | 615 | 739 | 653 | 542 | 989 | 926 | 1,017 | 1,000 | 942 | 555 | 499 | 500 | 468 | 543 | 342 | 392 | 409 | 428 | 430 | 462 |
Cash Equivalents | 129.5% | 221 | 96.00 | 234 | 147 | 91.00 | 118 | 119 | 492 | 447 | 500 | 148 | 66.00 | 134 | 105 | 121 | 60.00 | 68.00 | 61.00 | 58.00 | 56.00 | 56.00 |
Inventory | 23.1% | 132 | 108 | 100 | 103 | 98.00 | 48.00 | 54.00 | 56.00 | 59.00 | 58.00 | 61.00 | 58.00 | 48.00 | 41.00 | 29.00 | 36.00 | 44.00 | 31.00 | 23.00 | 18.00 | 8.00 |
Net PPE | - | - | - | - | - | - | - | - | - | 10.00 | 10.00 | 11.00 | 10.00 | 11.00 | 12.00 | 11.00 | 15.00 | 15.00 | 15.00 | 7.00 | 7.00 | 5.00 |
Goodwill | 0.1% | 417 | 416 | 409 | 199 | 199 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Liabilities | 1.6% | 1,659 | 1,634 | 1,672 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Liabilities | 26.6% | 116 | 92.00 | 131 | 109 | 200 | 112 | 117 | 113 | 114 | 107 | 421 | 27.00 | 26.00 | 42.00 | 86.00 | 108 | 135 | 139 | 149 | 139 | 132 |
Long Term Debt | - | - | - | 1,493 | - | 1,147 | 788 | 787 | 786 | 786 | 785 | - | 394 | 390 | 387 | 383 | 9.00 | 14.00 | 19.00 | 35.00 | 58.00 | 79.00 |
LT Debt, Current | - | - | - | 13.00 | 13.00 | 99.00 | 90.00 | 89.00 | 89.00 | 89.00 | 89.00 | 397 | - | - | 3.00 | 20.00 | 55.00 | 71.00 | 87.00 | 92.00 | 89.00 | 87.00 |
LT Debt, Non Current | 0.1% | 1,496 | 1,494 | 1,493 | 1,491 | - | - | 787 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | 129.4% | 151 | 66.00 | 170 | 97.00 | 293 | 260 | 197 | 282 | 120 | 68.00 | 151 | 99.00 | 106 | 58.00 | 92.00 | 245 | 260 | 260 | 249 | 240 | 255 |
Retained Earnings | 113.8% | 140 | 66.00 | 143 | 86.00 | 24.00 | 1.00 | -58.91 | -125 | -342 | -433 | -474 | -547 | -583 | -609 | -603 | -569 | -544 | -529 | -531 | -529 | -501 |
Additional Paid-In Capital | - | 12.00 | - | 27.00 | 13.00 | 271 | 262 | 256 | 407 | 462 | 501 | 625 | 646 | 688 | 668 | 695 | 814 | 804 | 789 | 780 | 769 | 757 |
Shares Outstanding | 0.1% | 132 | 132 | 135 | 135 | 138 | 138 | 137 | 142 | 142 | 138 | 135 | 137 | 136 | 137 | 137 | 146 | 145 | 145 | 145 | 144 | 144 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | 9.5% | 306 | 279 | 240 | 240 | 292 | 289 | 299 | 268 | 152 | 119 | 55.00 | -22.09 | -57.76 | -85.84 | -85.42 | -48.34 | -37.67 | -31.75 | -49.50 | 93.00 | 132 |
Share Based Compensation | 14.4% | 32.00 | 28.00 | 24.00 | 22.00 | 21.00 | 21.00 | 21.00 | 20.00 | 19.00 | 18.00 | 17.00 | 20.00 | 24.00 | 30.00 | 35.00 | 37.00 | 37.00 | 37.00 | 36.00 | 34.00 | 33.00 |
Cashflow From Investing | 98.4% | -7.92 | -497 | -487 | -784 | -800 | -410 | -406 | -48.38 | -61.52 | -5.00 | 78.00 | -102 | -31.81 | 4.00 | -5.55 | 128 | 122 | 67.00 | 2.00 | -157 | -162 |
Cashflow From Financing | -185.3% | -168 | 197 | 362 | 200 | 152 | -260 | 78.00 | 206 | 223 | 281 | -106 | 132 | 156 | 126 | 153 | -75.56 | -72.73 | -72.88 | -63.80 | -45.36 | -29.83 |
Buy Backs | 0% | 350 | 350 | 200 | 267 | 86.00 | 151 | - | 230 | 224 | 177 | 150 | 312 | 254 | 252 | 200 | - | - | - | - | - | - |
Condensed Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Revenues | ||||
Total revenues | $ 221,038 | $ 152,365 | $ 383,181 | $ 269,644 |
Operating expenses | ||||
Cost of sales | 50,070 | 33,943 | 85,240 | 49,865 |
Amortization of intangibles | 17,835 | 11,403 | 35,670 | 11,403 |
Research and development | 19,727 | 15,483 | 37,706 | 27,336 |
Selling, general and administrative | 38,948 | 57,476 | 76,305 | 71,310 |
Total operating expenses | 126,580 | 118,305 | 234,921 | 159,914 |
Operating income | 94,458 | 34,060 | 148,260 | 109,730 |
Other income (expense) | ||||
Investment and other income (expense), net | 3,192 | (945) | 6,171 | (447) |
Interest expense | (4,494) | (3,104) | (9,037) | (4,863) |
Net income before income taxes | 93,156 | 30,011 | 145,394 | 104,420 |
Income tax expense | 18,402 | 7,326 | 31,025 | 21,627 |
Net income | $ 74,754 | $ 22,685 | $ 114,369 | $ 82,793 |
Earnings per share | ||||
Basic (USD per share) | $ 0.57 | $ 0.16 | $ 0.86 | $ 0.60 |
Diluted (USD per share) | $ 0.56 | $ 0.16 | $ 0.84 | $ 0.58 |
Weighted average common shares outstanding | ||||
Basic (shares) | 131,730 | 137,937 | 133,369 | 137,798 |
Diluted (shares) | 133,543 | 142,216 | 135,758 | 141,795 |
Royalties | ||||
Revenues | ||||
Total revenues | $ 111,740 | $ 85,340 | $ 211,380 | $ 154,945 |
Product sales, net | ||||
Revenues | ||||
Total revenues | 73,889 | 46,300 | 134,683 | 68,440 |
Revenues under collaborative agreements | ||||
Revenues | ||||
Total revenues | $ 35,409 | $ 20,725 | $ 37,118 | $ 46,259 |
Condensed Consolidated Balance Sheets (Unaudited) - USD ($) | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 221,165,000 | $ 234,195,000 |
Marketable securities, available-for-sale | 127,110,000 | 128,599,000 |
Accounts receivable, net and contract assets | 246,179,000 | 231,072,000 |
Inventories, net | 132,406,000 | 100,123,000 |
Prepaid expenses and other current assets | 38,885,000 | 45,024,000 |
Total current assets | 765,745,000 | 739,013,000 |
Property and equipment, net | 74,559,000 | 75,570,000 |
Prepaid expenses and other assets | 18,409,000 | 26,301,000 |
Goodwill | 416,821,000 | 409,049,000 |
Intangible assets, net | 510,982,000 | 546,652,000 |
Deferred tax assets, net | 23,924,000 | 44,426,000 |
Restricted cash | 0 | 500,000 |
Total assets | 1,810,440,000 | 1,841,511,000 |
Current liabilities | ||
Accounts payable | 10,120,000 | 17,693,000 |
Accrued expenses | 105,431,000 | 96,516,000 |
Deferred revenue, current portion | 842,000 | 3,246,000 |
Current portion of long-term debt, net | 0 | 13,334,000 |
Total current liabilities | 116,393,000 | 130,789,000 |
Deferred revenue, net of current portion | 2,253,000 | 2,253,000 |
Long-term debt, net | 1,495,998,000 | 1,492,766,000 |
Other long-term liabilities | 30,875,000 | 30,433,000 |
Contingent liability | 13,888,000 | 15,472,000 |
Total liabilities | 1,659,407,000 | 1,671,713,000 |
Commitments and contingencies (Note 12) | ||
Stockholders’ equity | ||
Preferred stock - $0.001 par value; 20,000 shares authorized; no shares issued and outstanding | 0 | 0 |
Common stock - $0.001 par value; 300,000 shares authorized; 131,856 and 135,154 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively | 132,000 | 135,000 |
Additional paid-in capital | 12,068,000 | 27,368,000 |
Accumulated other comprehensive loss | (1,615,000) | (922,000) |
Retained earnings | 140,448,000 | 143,217,000 |
Total stockholders’ equity | 151,033,000 | 169,798,000 |
Total liabilities and stockholders’ equity | $ 1,810,440,000 | $ 1,841,511,000 |